These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31988310)
1. Guided migration analyses at the single-clone level uncover cellular targets of interest in tumor-associated myeloid-derived suppressor cell populations. Duarte-Sanmiguel S; Shukla V; Benner B; Moore J; Lemmerman L; Lawrence W; Panic A; Wang S; Idzkowski N; Guio-Vega G; Higuita-Castro N; Ghadiali S; Carson WE; Gallego-Perez D Sci Rep; 2020 Jan; 10(1):1189. PubMed ID: 31988310 [TBL] [Abstract][Full Text] [Related]
2. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
3. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer. Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521 [TBL] [Abstract][Full Text] [Related]
4. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models. Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449 [TBL] [Abstract][Full Text] [Related]
5. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862 [TBL] [Abstract][Full Text] [Related]
6. Single clonal tracking on biomimetic microtextured platforms for real-time guided migration analysis of myeloid-derived suppressor cell dissemination characteristics ex vivo. Panic A; Moore J; Gallego-Perez D Methods Cell Biol; 2024; 184():97-103. PubMed ID: 38555161 [TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer. Li F; Zhao Y; Wei L; Li S; Liu J Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426 [TBL] [Abstract][Full Text] [Related]
8. CXCL17-derived CD11b Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260 [TBL] [Abstract][Full Text] [Related]
9. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies. Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274 [TBL] [Abstract][Full Text] [Related]
10. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients. Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B Front Immunol; 2020; 11():613215. PubMed ID: 33679700 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer. Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment. Shukla VC; Duarte-Sanmiguel S; Panic A; Senthilvelan A; Moore J; Bobba C; Benner B; Carson WE; Ghadiali SN; Gallego-Perez D Adv Biosyst; 2020 Jun; 4(6):e2000049. PubMed ID: 32419350 [TBL] [Abstract][Full Text] [Related]
13. Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics. Alshetaiwi H; Pervolarakis N; McIntyre LL; Ma D; Nguyen Q; Rath JA; Nee K; Hernandez G; Evans K; Torosian L; Silva A; Walsh C; Kessenbrock K Sci Immunol; 2020 Feb; 5(44):. PubMed ID: 32086381 [TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation. Ai L; Mu S; Sun C; Fan F; Yan H; Qin Y; Cui G; Wang Y; Guo T; Mei H; Wang H; Hu Y Mol Cancer; 2019 Apr; 18(1):88. PubMed ID: 30979371 [TBL] [Abstract][Full Text] [Related]
15. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment. Lin Y; Li B; Yang X; Cai Q; Liu W; Tian M; Luo H; Yin W; Song Y; Shi Y; He R Neoplasia; 2019 Dec; 21(12):1133-1142. PubMed ID: 31759251 [TBL] [Abstract][Full Text] [Related]
16. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers. Lim HX; Kim TS; Poh CL Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443699 [TBL] [Abstract][Full Text] [Related]
17. Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment. Sceneay J; Griessinger CM; Hoffmann SHL; Wen SW; Wong CSF; Krumeich S; Kneilling M; Pichler BJ; Möller A PLoS One; 2018; 13(4):e0196040. PubMed ID: 29677215 [TBL] [Abstract][Full Text] [Related]